Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CCR1 | P32246 | 1/20 | 0.50 |
| ▸ | CCR8 | P51685 | 1/20 | 0.50 |
| ▸ | NOS3 | P29474 | 1/20 | 0.46 |
| ▸ | NOS2 | P35228 | 1/20 | 0.46 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.40 |
| ▸ | KDM4E | B2RXH2 | 4/20 | 0.40 |
| ▸ | HPGD | P15428 | 3/20 | 0.40 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.40 |
| ▸ | RAB9A | P51151 | 4/20 | 0.38 |
| ▸ | MEN1 | O00255 | 3/20 | 0.38 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.38 |
| ▸ | NPC1 | O15118 | 3/20 | 0.36 |
| ▸ | GRM5 | P41594 | 3/20 | 0.36 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.36 |
| ▸ | HDAC6 | Q9UBN7 | 2/20 | 0.36 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.36 |
| ▸ | CYP2D6 | P10635 | 2/20 | 0.36 |
| ▸ | CYP2C9 | P11712 | 2/20 | 0.36 |
| ▸ | PKM | P14618 | 2/20 | 0.36 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29380771 | 1.00 | CCR1 (0.50) | CCR1CCR8NOS3NOS2ALDH1A1 | |
| SCHEMBL20348778 | 0.87 | CCR1 (0.67) | CCR1CCR8NOS3NOS2ALDH1A1 | |
| SCHEMBL958741 | 0.85 | CCR1 (0.50) | CCR1CCR8NOS3NOS2ALDH1A1 | |
| SCHEMBL13821747 | 0.85 | CCR1 (0.50) | CCR1CCR8NOS3NOS2ALDH1A1 | |
| SCHEMBL18471313 | 0.84 | CCR1 (0.34) | CCR1CCR8NOS3NOS2ALDH1A1 | |
| SCHEMBL42955 | 0.84 | PGK1 (0.39) | CCR1CCR8ALDH1A1KDM4EHPGD | |
| SCHEMBL25458041 | 0.83 | CCR1 (0.48) | CCR1CCR8NOS3NOS2ALDH1A1 | |
| Iodide SCHEMBL2346492 | 0.81 | PGK1 (0.38) | CCR1CCR8ALDH1A1KDM4EHPGD | |
| Hydrochloric Acid SCHEMBL30595152 | 0.81 | PGK1 (0.38) | CCR1CCR8ALDH1A1KDM4EHPGD | |
| SCHEMBL12873766 | 0.81 | NOS3 (0.48) | CCR1CCR8NOS3NOS2ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 855 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-103122052-B | A kind of soft section of crystallizable segmented copolymer of complete saturated hard section and preparation method thereof | BEIJING UNIVERSITY OF CHEMICAL TECHNOLOGY (CN) | 2015-12-09 | — | — | CN | claimed |
| US-8697820-B2 | Process for preparing high-reactivity isobutene homo- or copolymers | BASF SE (DE) | 2014-04-15 | — | — | US | claimed |
| CN-103122052-A | Segmented copolymer with fully-saturated soft segment and crystallizable hard segment and preparation method of segmented copolymer | UNIV BEIJING CHEMICAL | 2013-05-29 | — | — | CN | claimed |
| CN-101987877-B | Cationic polymerization method of isotactic polymer | UNIV BEIJING CHEMICAL | 2012-10-17 | — | — | CN | claimed |
| EP-1172878-B1 | Non-aqueous electrolytic solution and secondary battery containing same | MITSUBISHI CHEM CORP (JP) | 2011-06-22 | — | — | EP | claimed |
| US-6767671-B2 | STABILITY; HEAT RESISTANCE | MITSUBISHI CHEMICAL CORPORATION (JP) | 2004-07-27 | — | — | US | claimed |
| US-20020025477-A1 | Non-aqueous electrolytic solution and secondary battery containing same | MITSUBISHI CHEMICAL CORPORATION (JP) | 2002-02-28 | — | — | US | claimed |
| EP-1172878-A2 | Non-aqueous electrolytic solution and secondary battery containing same | MITSUBISHI CHEMICAL CORPORATION (JP) | 2002-01-16 | — | — | EP | claimed |
| EP-4508101-B1 | PROCESS FOR MANUFACTURING OF POLYISOBUTENE SUCCINIC ANHYDRIDES | BASF SE (DE) | 2026-03-25 | — | — | EP | disclosed |
| EP-4709518-A1 | PROCESS FOR THE PREPARATION OF POLYISOBUTENE FROM OLEFINS FROM ISOBUTANOL OBTAINED FROM MIXED GUERBET REACTION OF ETHANOL AND METHANOL | BASF SE (DE) | 2026-03-18 | — | — | EP | disclosed |
| EP-4667447-A1 | PROCESS FOR THE PREPARATION OF POLYISOBUTENE FROM BIO-BASED OLEFINS FROM PRIMARY ALCOHOL | BASF SE (DE) | 2025-12-24 | — | — | EP | disclosed |
| US-20250250382-A1 | PROCESS FOR MANUFACTURING OF POLYISOBUTENE SUCCINIC ANHYDRIDES | BASF SE (DE) | 2025-08-07 | — | — | US | disclosed |
| US-20250250403-A1 | PROCESS FOR MANUFACTURING OF POLYISOBUTENE SUCCINIC ANHYDRIDES | BASF SE (DE) | 2025-08-07 | — | — | US | disclosed |
| US-20250179224-A1 | MEDIUM MOLECULAR POLYISOBUTENE WITH A CERTAIN DISTRIBUTION OF DOUBLE BOND ISOMERS | BASF SE (DE) | 2025-06-05 | — | — | US | disclosed |
| US-20040235939-A1 | Synthesis of peloruside a and analogs thereof for use as antitumor agents | UNIVERSITY OF TEXAS SYSTEM, THE | 2004-11-25 | — | — | US | disclosed |
| WO-2004074249-A2 | SYNTHESIS OF PELORUSIDE A AND ANALOGS THEREOF FOR USE AS ANTITUMOR AGENTS | BOARD OF REGENTS, UNIVERSITY OF TEXAS SYSTEM (US) | 2004-09-02 | — | — | WO | disclosed |
| US-6767671-B2 | STABILITY; HEAT RESISTANCE | MITSUBISHI CHEMICAL CORPORATION (JP) | 2004-07-27 | — | — | US | disclosed |
| US-20040082578-A1 | Arylindenopyridines and related therapeutic and prophylactic methods | ORTHO-MCNEIL PHARMACEUTICAL, INC. | 2004-04-29 | — | — | US | disclosed |
| US-20020025477-A1 | Non-aqueous electrolytic solution and secondary battery containing same | MITSUBISHI CHEMICAL CORPORATION (JP) | 2002-02-28 | — | — | US | disclosed |
| EP-1172878-A2 | Non-aqueous electrolytic solution and secondary battery containing same | MITSUBISHI CHEMICAL CORPORATION (JP) | 2002-01-16 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040082578-A1 | Arylindenopyridines and related therapeutic and prophylactic methods | ADORA2A, ADORA1, PDE2A | CCR1 488/4885CCR8 1576/4885NOS3 675/4885 |
| US-20040235939-A1 | Synthesis of peloruside a and analogs thereof for use as antitumor agents | MAP4, MAPRE1, TUBA4A | CCR1 4741/4885CCR8 4294/4885NOS3 4251/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.